PATENT CLAIM ANALYSIS

Application Number: 16098535
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "613000"]

Abstract:
The present invention provides compositions and methods useful for treating and/or preventing Herpesviridae viral infections in a mammal. In certain embodiments, the virus comprises human  cytomegalovirus.

Claim (Index 1):
A method of treating or preventing an infection by a Herpesviridae family virus in a mammalian subject, the method comprising administering to the subject a therapeutically effective amount of at least one compound selected from the group consisting of:\n valnoctamide (2-ethyl-3-methylpentanamide) tert-butylethylacetamide (TED; 2-ethyl-3,3-dimethylbutanamide) and a molecule of formula (I): wherein\n a is 0,1,2,3 or4; \n b is 1, 2 or 3; \n c is 1, 2 or 3; and \n R is selected from the group consisting of H and C  1 -C 4  alkyl; \n or a solvate, salt, enantiomer, or diastereoisomer thereof, or any mixtures thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 98.0
- Lexical Diversity: 1.03571
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15361150', '14394973', '13579967', '13700049', '13438616']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7656635182824842
- 35 USC 102 Novelty (BERT): 0.5078859621266136
- Combined Prediction Score: 0.7398857626668972
- Mean Citation Score: 280.085358
- Max Citation Score: 291.64615
- Similarity Product: 226.95511411157844

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test